Zevra outlines CHMP reexamination timing with Q4 opinion expected, as MIPLYFFA Orange Book listing extends to 2041 — See source for full details.
$ZVRA
Price history, market instrument context, member research, and related headlines in one place.
ZVRA key statistics
NasdaqGSUSD
52-week range
$8.0132%$15.04
Latest session $10.22–$10.60Zevra Therapeutics, Inc. (ZVRA) is a stock instrument quoted on NasdaqGS in USD. The most recently published price is $10.27, up $0.04 (0.39%) from the previous close of $10.23. It has traded between $10.22 and $10.60 in the latest session. Over the past year it has ranged from $8.01 to $15.04, leaving it in the lower half of its 52-week range (32%). Reported volume for the session was 462.4K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
Loading $ZVRA research…